Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Iben Kümler

Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant

ESMO Open

Cancer Research

Oncology

2016

English

Related publications

Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer

Clinical Breast Cancer

Cancer Research

Oncology

2012

English

Persistence in Patients With Breast Cancer Treated With Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer Database

English

Patients’ Preferences for Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Treatments in Japan

English

Fulvestrant 500mg Versus Exemestane in Postmenopausal Metastatic Breast Cancer (MBC) Resistant to Adjuvant Non-Steroidal Aromatase Inhibitors (NSAI) in Clinical Practice – A Multicenter Retrospective Study

Clinical Breast Cancer

Cancer Research

Oncology

2019

English

Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

English

Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index

British Journal of Cancer

Cancer Research

Oncology

2012

English

Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Clinical Breast Cancer

Cancer Research

Oncology

2014

English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2003

English

Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients With Early Breast Cancer: A Propensity Score‐Matched Cohort Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Iben Kümler

Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant

Related publications

Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer

Persistence in Patients With Breast Cancer Treated With Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer Database

Patients’ Preferences for Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Treatments in Japan

Fulvestrant 500mg Versus Exemestane in Postmenopausal Metastatic Breast Cancer (MBC) Resistant to Adjuvant Non-Steroidal Aromatase Inhibitors (NSAI) in Clinical Practice – A Multicenter Retrospective Study

Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index

Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients With Early Breast Cancer: A Propensity Score‐Matched Cohort Study